Many U.S. companies continue cutting back health care spending, forcing labs to confront an increased number of patient collections if consumers need to pay for lab testing out-of-pocket. This could lead to an increase in average days in accounts receivable (AR), as well as bad-debt expense for some labs.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

April 2008 - Table of Contents

LIR April 2008 (full PDF issue)

Quest Partners With Google to Develop Portable PHR

Debt Load and Economy's Financial Crisis Put Pressure on Bostwick Labs' $100M IPO

Top 10 Lab and Pathology Tests—Surgical Path Leads With $20 Billion in Medicare Dollars

Lab Financial Benchmarks Reveal Psychemedics Tops Productivity Measures

NY Market Shift Helps Boost Bio-Reference, but DSO Benchmarks Cause Concern

Receivables, Bad Debt Could Rise as Economic Downturn Challenges Labs

Sonic Projects 20% to 25% Growth in ’08 as Federated Model and Acquisitions Pose Challenge

Ikonisys Gets CLIA Registration for Niche Reference Lab

Lab Stocks Take a Hit in March; Index Down 12% Over 5 Weeks

Stanford’s Basic Outreach Testing Unit for Sale